ADCs that deliver: The secret lies in rigorous characterization
Explore the challenges of ADC characterization, key techniques, and the benefits of partnering with a CDMO for effective development.
Don't miss out on the next big biotech breakthrough
Get all the latest updates straight into your inbox!
Newsletter Signup - Home CTA
"*" indicates required fields
-
In DepthSeptember 18, 2024Two targets, one solution: The rise of bispecific antibodies
-
Best in BiotechSeptember 17, 2024Estonia: Seven biotech companies to reckon with
-
News and TrendsSeptember 16, 2024Vironexis’ AAV vector approach: The next frontier in cancer immunology?
-
Expert AdviceSeptember 13, 2024Stealth mode biotech startups: Everything you need to know
- Latest Posts
- Popular Posts
Podcast 13 Sep 2024Targeting inflammation: A revolution in disease treatment
NLRP3 inflammasome-induced inflammation is at the root of nearly all disease pathologies. Listen to our conversation with Halia Therapeutics about it.
In Depth 12 Sep 2024New treatments being developed for schizophrenia
Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials.
News and Trends 12 Sep 2024Biotech R&D crunch: The impact of the Inflation Reduction Act and economic challenges
Delve into the consequences of the Inflation Reduction Act and the broader economic conditions on biotech R&D.
News and Trends 11 Sep 2024Can Europe revive its biopharma innovation leadership?
Find out if the biotech runner-up, Europe, can step up to boost research and revive its innovation leadership.
News and Trends 10 Sep 2024Long non-coding RNAs: what’s behind the growing “dark genome” buzz?
Recent deals have zoned in on drugs that target long non-coding RNAs and major moves are currently being made on the R&D front.ADVERTISEMENT
ADVERTISEMENT
Accelerating the path to clinical filing applications with rapid toxicology material delivery
Pre-clinical toxicology studies and prompt material delivery are essential for IND and CTA approvals, crucial for advancing drug candidates to clinical trials.
News and Trends 6 Sep 2024Psychedelic therapies under scrutiny: What’s next after Lykos’ MDMA rejection?
Delve into the psychedelic-assisted therapy market and investors’ sentiment after the FDA’s decision about Lykos’ therapy.
Podcast 6 Sep 2024The power of tumor infiltrating lymphocytes to fight melanoma
Listen to our conversation with Brian Gastman, EVP of medical affairs at Iovance Biotherapeutics, about TILs and the company’s pipeline.
In Depth 5 Sep 2024The biggest private biotech investments in August 2024
The companies Borealis Biosciences, Outpace Bio, and Halda Therapeutics bagged the biggest private biotech investments in August 2024.
Best in Biotech 5 Sep 2024Six biotech companies that could revolutionize obesity treatments
In this article, we take a look at six biotechs focused on bringing drugs to treat obesity to the market.
News and Trends 4 Sep 20242024: a year of breakthroughs for endometrial cancer?
New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs.
Expert Advice 2 Feb 20245 biotech career paths where demand is skyrocketing
Check out five important biotechnology careers that are currently in high demand, and likely still will be in the coming years.
Best in Biotech 12 Mar 2024The twelve hottest biotech companies in the Boston area
Explore Boston’s vibrant biotech landscape with twelve innovative companies leading the charge in life sciences research.
In Depth 12 Feb 2024RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing?
Find out all about about RNA editing, as two candidates have just managed to reach the clinic for the first time.
In Depth 15 Jan 2024The future of diabetes treatment: Is a cure possible?
Diabetes has become an epidemic. Science is striving to find a diabetes treatment that can cure this chronic disease, but how close are we?
In Depth 8 Feb 2024Could we see a new dawn for hair loss treatments?
Discover the latest advances in hair loss treatments, from topical therapies to the the groundbreaking potential of JAK inhibitors.
Best in Biotech 5 Jan 2024Five AI drug discovery companies you should know about
Take a look at five of the top AI drug discovery companies around today, using their technology to speed up the drug discovery process.
Expert Advice 15 Mar 2024Is biotechnology a good career? Here are the pros and cons
Find out about the pros and cons of pursuing a career in biotechnology, from competitive salaries to dealing with regulatory hurdles.
In Depth 9 Feb 2024Biotech job market 2024: what to expect?
The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year?
Podcast 19 Jan 2024Epigenetic editing – the power of CRISPR without cutting DNA
Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies […]
Best in Biotech 12 Apr 20246 biotechnology universities in the US nurturing tomorrow’s trailblazers
Discover the top biotechnology universities in the US offering cutting-edge programs that are helping students find a career in biotech.
In Depth 8 Jul 2024Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR
Find out how the recent discovery of a molecular oddity found in bacteria has led to a new gene editing technique.
Best in Biotech 13 Feb 2024Eight biotechs thriving in Seattle
In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large.
ADVERTISEMENT